NL
DE
Research
Hematology
About
We want to develop innovative and effective forms of supportive and integrated care to reduce toxicity and improve tolerability of therapy.
Aims
- Prevention or treatment of mucosal barrier injury and induced inflammatory complications like mucositis, infections and graft versus host disease (GvHD)
- To increase drug adherence and improve tolerability of oral cancer therapy
- To promote self-management and fitness as a person living with chronic malignant diseases
